Do menopause weight loss pills work?
Over-the-counter menopause weight loss pills have little or no evidence. They are supplements, sold without FDA review of their effectiveness, and the best studied ingredient, berberine, averaged under 1 kg of weight loss. Prescription medicines are a different category: in the STEP 1 trial, semaglutide led to about 15 percent weight loss over 68 weeks. Whether a prescription medicine suits you is a conversation with your doctor. With any approach, high protein and strength training help protect muscle.
Key takeaways
- Menopause weight loss pills sold over the counter are supplements, not medicines.
- Supplements do not need FDA approval before sale, and neither do their weight loss claims.
- Berberine, the best studied ingredient, reduced weight by 0.88 kg on average across 23 studies.
- Prescription GLP-1 medicines are in a different league: 14.9 percent weight loss with semaglutide in STEP 1.
- The FDA warns against unapproved versions of GLP-1 drugs sold without a prescription.
- Whatever you choose, keep protein high and train, so the weight you lose is mostly fat.
Weight gain in the menopause transition is common, frustrating, and a big market. Pills sold for menopause weight loss promise to fix it without effort. The evidence divides them into two very different groups.
Over-the-counter pills: supplements, not medicines
Menopause weight loss pills sold in shops and online are dietary supplements. They do not need FDA approval before they are sold, and the FDA generally does not approve their claims either.1 Ingredients vary from product to product.
Berberine is the best studied. In a 2026 meta-analysis of 23 studies, it reduced body weight by 0.88 kg on average compared with control.2 That is real, and it is small.
Prescription medicines: a different league
| Average weight change | Evidence | |
|---|---|---|
| Semaglutide (prescription) | 14.9% of body weight over 68 weeks, vs 2.4% on placebo | Large randomized trial |
| GLP-1 medicines in general | 5 to 18% in trials | 2025 joint nutrition advisory |
| Berberine (supplement) | 0.88 kg more than control | Meta-analysis of 23 studies |
| Most menopause diet pills | Not tested | No approval needed |
In the STEP 1 trial, adults with overweight or obesity taking semaglutide lost 14.9 percent of their body weight over 68 weeks, against 2.4 percent with placebo.3 The 2025 joint advisory from four obesity and nutrition societies summarizes GLP-1 medicines as reducing weight by 5 to 18 percent in trials, with somewhat smaller effects in real-world use, and notes challenges including side effects, nutrient gaps, and muscle and bone loss.5
These medicines need a prescription, and whether they suit you depends on your weight, health and history, so the first step is your doctor. Before starting a GLP-1 lists what to put in place.
Avoid unapproved versions
Products sold online as semaglutide or tirzepatide without a prescription, or as drops and sprays, are not approved medicines. The FDA warns that unapproved versions of GLP-1 drugs do not go through its review for safety, effectiveness and quality, and advises getting a prescription and filling it at a state-licensed pharmacy.4
Whatever you choose, protect your muscle
Muscle is already declining in midlife, and any weight loss, with or without a pill, can take muscle along with fat. Protein is the main defence. In a meta-analysis of 24 trials, higher protein diets with the same calories kept about 0.4 kg more lean mass and led to slightly more fat loss than standard protein diets.6 The Dietary Guidelines for Americans 2025 to 2030 set a goal of 1.2 to 1.6 g of protein per kilogram of body weight a day.7
- Keep protein at 25 to 30 g per meal while calories come down.
- Strength train two or three times a week.
- Measure your waist as well as your weight.
Protein Buddy works out a daily protein target from a short quiz on your weight, age, activity, goal and whether you take a GLP-1, and Home shows how many grams are left today as you log. Typing meals in by hand is free with no limit. Perimenopause weight gain explains why weight changes in these years, and menopause belly fat covers the waist.
If you already take a GLP-1 medicine, supplements to take on a GLP-1 covers what is worth adding.
Talk to your doctor
See a doctor before taking any weight loss pill, including supplements, especially if you take other medicines, since some ingredients can interfere with them. Weight gain that is fast or comes with other new symptoms should be checked for other causes.
More questions about Women over 40
What is the best weight loss pill for menopause?
No over-the-counter pill has good evidence. If weight is affecting your health, prescription weight loss medicines such as GLP-1 medicines have strong trial evidence, and a doctor can tell you whether you qualify and whether they suit you.
Do menopause belly fat pills work?
No supplement has been shown to reduce belly fat. Belly fat shrinks with overall fat loss, helped by a calorie deficit, exercise and enough protein to keep muscle.
Can hormone therapy help with menopause weight loss?
Hormone therapy is not a weight loss treatment. It is the most effective treatment for hot flashes and helps prevent bone loss. Weight management in menopause still depends on diet, activity and, for some women, prescription weight loss medicine.
Are online GLP-1 pills or drops safe?
Products sold as semaglutide or tirzepatide without a prescription are unapproved drugs. The FDA warns they do not go through its review for safety, effectiveness and quality, and advises getting a prescription from your doctor and filling it at a state-licensed pharmacy.
How much protein do I need while losing weight in menopause?
The Dietary Guidelines for Americans set a goal of 1.2 to 1.6 g per kilogram of body weight a day. Keeping protein high while calories fall helps protect muscle: higher protein diets kept about 0.4 kg more lean mass in a meta-analysis of weight loss trials.
References
- Questions and Answers on Dietary Supplements
- The effect of berberine on obesity indices: a systematic review and meta-analysis
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
- Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
- Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials
- Dietary Guidelines for Americans, 2025-2030
